Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Reshape Lifesciences Inc (RSLS)

Reshape Lifesciences Inc (RSLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,422
  • Shares Outstanding, K 13,135
  • Annual Sales, $ 11,240 K
  • Annual Income, $ -46,210 K
  • 60-Month Beta 0.19
  • Price/Sales 0.04
  • Price/Cash Flow N/A
  • Price/Book 0.20
Trade RSLS with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -3.66
  • Most Recent Earnings $-1.02 on 11/08/23
  • Latest Earnings Date 04/23/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year -1,182.51
  • Growth Rate Est. (year over year) +184.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1456 +26.65%
on 03/07/24
0.1980 -6.87%
on 03/28/24
+0.0119 (+6.90%)
since 02/28/24
3-Month
0.1414 +30.41%
on 02/14/24
0.2994 -38.41%
on 01/10/24
-0.0712 (-27.86%)
since 12/28/23
52-Week
0.1414 +30.41%
on 02/14/24
4.1000 -95.50%
on 04/17/23
-2.9356 (-94.09%)
since 03/28/23

Most Recent Stories

More News
ReShape Lifesciencesâ„¢ to Announce Financial Results for the Second Quarter Ended June 30, 2022 and Provide Corporate Update

Conference Call to be Held at 4:30 pm ET on Monday, August 15 , 2022...

RSLS : 0.1844 (+1.77%)
ReShape Lifesciencesâ„¢ Receives FDA 510(k) Clearance for the GIBI HDâ„¢ Calibration Tubes for use in Gastric and Bariatric Procedures

New Calibration Tubes, in Three Sizes, Will Simplify Gastric and Bariatric Procedures Including Laparoscopic Sleeve Gastrectomy, Gastric Bypass and Gastric...

RSLS : 0.1844 (+1.77%)
ReShape Lifesciences Announces Appointment of Paul F. Hickey as President and Chief Executive Officer

SAN CLEMENTE, Calif., July 27, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciencesâ„¢ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health...

RSLS : 0.1844 (+1.77%)
ReShape Lifesciences Enters into Warrant Exercise Transaction for $2.5 Million in Gross Proceeds

SAN CLEMENTE, Calif., June 17, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic...

RSLS : 0.1844 (+1.77%)
ReShape Lifesciences and OpenLoop Sign Agreement to Provide Nationwide Virtual Health Services for Weight Loss and Wellness Through reshapecareâ„¢

Solution will Provide Physician-Led Virtual Weight Loss Coaching...

RSLS : 0.1844 (+1.77%)
ReShape Lifesciencesâ„¢ Reports First Quarter 2022 Financial Results and Provides Corporate Update

March 2022 Revenues Exceeded January’s and February’s, Combined, Indicating DTC Campaign and Other Visibility Activities are Driving Significant Demand for...

RSLS : 0.1844 (+1.77%)
ReShape Lifesciencesâ„¢ Announces Vernon Vincent to be Recognized as the Distinguished Industry Partner at the ASMBS 2022 LEAD Gala and Awards

SAN CLEMENTE, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- ReShape Lifesciencesâ„¢ (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health...

RSLS : 0.1844 (+1.77%)
ReShape Lifesciencesâ„¢ to Announce Financial Results for the First Quarter Ended March 31, 2022 and Provide Corporate Update

Webcast to be Held at 8:30 am ET on Monday, May 23, 2022...

RSLS : 0.1844 (+1.77%)
ReShape Lifesciences to Present at the Q2 Investor Summit

Management will also Present to Members of the Philadelphia Securities Association...

RSLS : 0.1844 (+1.77%)
ReShape Lifesciencesâ„¢ Reports Year Ended 2021 Financial and Operating Results and Provides Corporate Update

Conference Call to be Held at 5:30 pm ET Today...

RSLS : 0.1844 (+1.77%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

ReShape Lifesciences Inc. provides weight-loss solutions. It offers an integrated portfolio of proven products and services which manage and treat obesity and metabolic disease. ReShape Lifesciences Inc., formerly known as Obalon Therapeutics, is based in SAN CLEMENTE, CA.

See More

Key Turning Points

3rd Resistance Point 0.2129
2nd Resistance Point 0.2055
1st Resistance Point 0.1949
Last Price 0.1844
1st Support Level 0.1769
2nd Support Level 0.1695
3rd Support Level 0.1589

See More

52-Week High 4.1000
Fibonacci 61.8% 2.5878
Fibonacci 50% 2.1207
Fibonacci 38.2% 1.6536
Last Price 0.1844
52-Week Low 0.1414

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar